Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5169402
Max Phase: Preclinical
Molecular Formula: C33H35N3O9
Molecular Weight: 617.66
Associated Items:
ID: ALA5169402
Max Phase: Preclinical
Molecular Formula: C33H35N3O9
Molecular Weight: 617.66
Associated Items:
Canonical SMILES: C/C=C(/C)C(=O)OC[C@H]1c2c(c(OC(C)=O)c(C)c3c2OCO3)C[C@H]2[C@H]3C4=C(C[C@@H]([C@H](C#N)N12)N3C)C(=O)C(C)=C(OC)C4=O
Standard InChI: InChI=1S/C33H35N3O9/c1-8-14(2)33(40)42-12-23-24-19(29(45-17(5)37)16(4)31-32(24)44-13-43-31)10-21-26-25-18(27(38)15(3)30(41-7)28(25)39)9-20(35(26)6)22(11-34)36(21)23/h8,20-23,26H,9-10,12-13H2,1-7H3/b14-8-/t20-,21-,22-,23-,26-/m0/s1
Standard InChI Key: FMTJPQKNNAGUKI-RKVQHWSPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 617.66 | Molecular Weight (Monoisotopic): 617.2373 | AlogP: 2.77 | #Rotatable Bonds: 5 |
Polar Surface Area: 144.70 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 3.11 | CX LogP: 3.62 | CX LogD: 3.62 |
Aromatic Rings: 1 | Heavy Atoms: 45 | QED Weighted: 0.21 | Np Likeness Score: 2.19 |
1. Fang Y, Li H, Ji B, Cheng K, Wu B, Li Z, Zheng C, Hua H, Li D.. (2021) Renieramycin-type alkaloids from marine-derived organisms: Synthetic chemistry, biological activity and structural modification., 210 [PMID:33333398] [10.1016/j.ejmech.2020.113092] |
2. Yokoya M, Yamazaki-Nakai M, Nakai K, Sirimangkalakitti N, Chamni S, Suwanborirux K, Saito N.. (2023) Transformation of Renieramycin M into Renieramycins T and S by Intramolecular Photoredox Reaction of 7-Methoxy-6-methyl-1,2,3,4-tetrahydroisoquinoline-5,8-dione Derivatives., 86 (1.0): [PMID:36631738] [10.1021/acs.jnatprod.2c00974] |
Source(1):